PubRank

F Di Filippo

Author PubWeight™ 28.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 1997 1.42
2 Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines. J Immunother 2001 1.42
3 Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol 1998 1.14
4 Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol 2010 0.99
5 S-100 and NSE as serum markers in melanoma. Acta Oncol 1997 0.94
6 Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000 0.92
7 Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. J Cancer Res Clin Oncol 2000 0.91
8 Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer 1995 0.90
9 Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study. J Am Coll Surg 2000 0.90
10 Ia-like antigens on freshly explanted human melanoma. Clin Immunol Immunopathol 1981 0.89
11 A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study. Clin Cancer Res 2001 0.87
12 Class I major histocompatibility complex enhancement by recombinant leukocyte interferon in the peripheral blood mononuclear cells and plasma of melanoma patients. Cancer Res 1991 0.86
13 Selective location of palisaded myofibroblastoma with amianthoid fibres. J Clin Pathol 1991 0.85
14 Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion. Cancer 1999 0.84
15 Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. A preliminary finding. Dis Colon Rectum 1989 0.83
16 Nipple sparing mastectomy with immediate breast reconstruction: a short term analysis of our experience. J Exp Clin Cancer Res 2006 0.82
17 Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment. J Intern Med 2012 0.81
18 Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon. Int J Cancer 1990 0.81
19 An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei. J Exp Clin Cancer Res 2003 0.81
20 [Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer]. Clin Ter 2009 0.81
21 Flow cytometric study of lymphocyte subsets in patients at different stages of colorectal carcinoma. Dis Colon Rectum 1994 0.81
22 Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Oncol 2000 0.81
23 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study. In Vivo 2007 0.80
24 Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha. J Exp Clin Cancer Res 2004 0.78
25 The integrated treatment of peritoneal carcinomatosis. A preliminary experience. J Exp Clin Cancer Res 1999 0.78
26 Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status. J Exp Clin Cancer Res 2007 0.78
27 Melan-A/MART-1 antigen expression in cutaneous and ocular melanomas. J Immunother 1997 0.78
28 [Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology]. Tumori 2003 0.78
29 Immunocytochemical diagnosis of amelanotic metastatic melanoma using monoclonal antibodies HMB-45 and Ep1-3. Melanoma Res 1994 0.77
30 [Clinical guidelines for the management of gastrointestinal stromal tumors]. Clin Ter 2006 0.77
31 The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities. World J Surg 1988 0.77
32 Debate on Di Bella therapy. Lancet 1999 0.75
33 Thermochemotherapy for soft tissue sarcomas. Cancer Treat Res 1991 0.75
34 [Hyperthermic perfusion in the local-regional treatment of neoplasms, by use of experimental models]. Ann Ital Chir 1979 0.75
35 Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results. Oncology 1984 0.75
36 Hyperthermic antiblastic perfusion in the treatment of local recurrence or "in-transit" metastases of limb melanoma. Semin Surg Oncol 1992 0.75
37 Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic features. J Exp Clin Cancer Res 2003 0.75
38 Hyperthermia and chemotherapy by regional perfusion for tumors of the extremities. Prog Clin Biol Res 1982 0.75
39 Isolated limb perfusion: the European experience. Surg Oncol Clin N Am 2001 0.75
40 [The presurgical staging of soft-tissue sarcomas of the extremities: imaging diagnosis]. Radiol Med 1991 0.75
41 Role of hyperthermic perfusion in the treatment of limb osteogenic sarcoma. Oncology 1987 0.75
42 Thermochemotherapy for soft tissue sarcoma. Cancer Treat Res 1989 0.75
43 Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells. Oncology 1984 0.75
44 Hyperthermic perfusion 16 years after its first clinical applications. Henry Ford Hosp Med J 1981 0.75
45 Paclitaxel-induced nail changes: possible role of its vehicle (Cremophor EL). Eur J Dermatol 2007 0.75
46 [Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer]. Clin Ter 2009 0.75
47 Radical surgery in rectal cancer patients: what does it mean today? J Surg Oncol Suppl 1991 0.75
48 Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences. Melanoma Res 1994 0.75